Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00533546 · ClinicalTrials.gov registry record · Phase 2
Activated Protein C in Acute Stroke Trial
A Phase 2 study, sponsored by University of Rochester.
- Terminated
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
NCT00533546 is a Phase 2 study that was terminated before completion, run by University of Rochester. The registered enrollment target is 12 participants.
The verdict
NCT00533546, a Phase 2 study, was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine the safety and learn more about the dose of Activated Protein C (APC) in reducing the damage from stroke.
Interventions
- DRUG Activated Protein C
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2007-09 |
| Est. Completion | 2010-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00533546
The ClinicalTrials.gov registry entry for NCT00533546 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Activated Protein C is the first listed.
NCT00533546 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00533546 about?
NCT00533546 is a clinical study titled "Activated Protein C in Acute Stroke Trial". The purpose of this research study is to determine the safety and learn more about the dose of Activated Protein C (APC) in reducing the damage from stroke.
What is the current status of trial NCT00533546?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2007-09. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00533546?
The interventions under investigation include: Activated Protein C (DRUG).
Who is sponsoring clinical trial NCT00533546?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.